SFB 1403 "Cell Death in Immunity, Inflammation and Disease"
Graphisches Slider Element
SFB 1403 Overview
Research within SFB1403 aims to understand the mechanisms of regulation and the functional role of diverse forms of regulated cell death in animals and plants, with particular focus on how different types of cell death regulate immunity, host-microbe interactions, inflammation and disease.
Graphisches Slider Element
News
Protein in inflammatory disease identified
Plant MLKL Publication is out
Children University 2024
“Sauer macht lustig – oder?”
SFB 1403 goes 2nd Funding period
CDD Jürg Tschopp Prize to Manolis Pasparakis
Congratulations to Manolis Pasparakis
Jane Parker elected to the National Academy of Sciences
Jane Parker elected to the National Academy of Sciences
Molecules boosting plant immunity identified
Long lasting activation of innate immunity following COVID-19 mRNA vaccination - signaling pathway deciphered
Children University 2022
Workshop all about Bacteria and Viruses in our body
New SFB 1403 Junior Group Leader
We are excited to welcome Dr. Hirotsugu Oda our new Junior Research Group Leader.
SFB 1403 members win "startup your idea" competition
New start up "Cell ImAIging" wins the startup your idea price.
New SFB 1403 Junior Group Leader
We are excited to welcome Dr. Christina Ising our new Junior Research Group Leader.
Congrats to new CCCE Junior Group Leader Melanie Fritsch
After obtaining her PhD from the University of Cologne in genetics, Melanie started a PostDoc in Cologne, focusing on the regulation of programmed cell death by the protease Caspase-8. Her CCCE junior research group will investigate the alteration of cell death machinery, which has traditionally been viewed as a central feature of malignant transformation and therapy resistance in cancer patients.
Professor Dr. Hamid Kashkar appointed to W3 professorship in Molecular Immunology
Prof. Dr. Hamid Kashkar, previously at the Institute of Medical Microbiology, Immunology and Hygiene and at the research cluster CECAD as a research group leader, will receive a W3 professorship for Molecular Immunology at the Medical Faculty of the University of Cologne as of January 1, 2022.